arrow
J

José Jalife

centro nacional de investigaciones cardiovasculares
H指数:106
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ventricular fibrillation dynamics reveal regional asymmetry in resilience to cardiac arrest and predict clinical outcome

室颤动力学揭示对心脏骤停的恢复力存在区域不对称性并预测临床结局

2026-05-280
OAAI
Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation

Lgi3-4蛋白调控KV1.5通道复合体,是心房颤动的潜在治疗靶点

2026-03-011
PRE
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference

通过针对合并症并减少心房颤动负荷来改变心房颤动管理:第10届AFNET/EHRA共识会议

2025-12-010
PRE
Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation
2024-08-014
OAAI
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)

重新审视心房心肌病-概念的演变: ESC欧洲心律协会 (EHRA),心律协会 (HRS),亚太心律协会 (APHRS) 和拉丁美洲心律协会 (LAHRS) 的临床共识声明

2024-07-300
OAAI
Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome
2024-04-120
PRE
The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3
2024-01-235
OAAI
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
CELLS
IF5.2
2023-07-270
OAAI
Distinct spectral dynamics of implanted cardiac defibrillator signals in spontaneous termination of polymorphic ventricular tachycardia and fibrillation in patients with electrical and structural diseases
2022-07-190
OA